Penicillins Flashcards
(37 cards)
β-lactam Mechanism of Action
watch video:
https://www.youtube.com/watch?v=qBdYnRhdWcQ
Penicillin Binding Proteins (PBPs)
• Enzymes which act as catalysts in synthesis of the
peptidoglycan cell wall
• Many different types and amounts of PBPs in different
bacteria (related bacteria similar)
• Numbered by decreasing size in each different type of
bacteria.
- Therefore: PBP1 in S. aureus ≠ PBP1 in E. coli
- Different PBPs may have different effects on cell
Effects of E. coli PBPs
• PBP 1a, 1b cause cell elongation
(inhibition causes rapid cell lysis)
• PBP 2 determine bacterial shape
(inhibition → stable round forms which grow for several
generations then lyse)
• PBP 3 involved in cell division
(inhibition → filamentous forms which grow for 5-6
generations then become deformed and die)
• PBP 4, 5, 6 of little consequence
Resistance to β-Lactams
- Production of β-lactamases
- Reduced affinity of PBP for β-lactam antibacterials
- Impermeability of cell membrane
- Efflux
- Organisms lacking a cell wall, (e.g., Mycoplasma)
- Tolerance (↓ activity of autolysins)
Classes of Penicillin
Antibacterials
Natural Penicillins
Penicillin G, Penicillin V
Penicillinase-resistant Penicillins
Cloxacillin
Aminopenicillins
Ampicillin, Amoxicillin
Carboxypenicillins
(Ticarcillin → no longer available in Canada)
Ureidopenicillins
Piperacillin
Spectrum of Activity of
Penicillin G, Penicillin V
• Most active against non-β-lactamase producing
Gram-positive bacteria, but we have seen increasing
resistance
• Anaerobes (Gram-positive)
- However, there are β-lactamase producing strains
- B. fragilis is Gram-negative and not covered
• Selected Gram-negative cocci
- e.g., Neisseria meningitidis
penV more resistant to stomach acid especially with potassium salt
penG more orally
Narrow spetrum
Not for empiric treatment
Known pathogen
Spectrum of Activity of Penicillin G
see slide 11
Resistance to Penicillin
Staphylococcus aureus
• most now produce β-lactamases
• some have altered PBPs (MRSA)
- PBP2a are produced that can take over role of PBPs
bound by penicillins - results in resistance to almost
all β-lactams
- Incidence MRSA Edmonton
* Dynalife 2008 (19%), 2019 (25%)
* UAH 2008 (28%), 2019 (23%)
• in some areas in US > 50% of S. aureus are MRSA
Resistance to Penicillin
Staphylococcus epidermidis (CoNS)
• Most produce β-lactamase
• Many have changes in PBPs resulting in resistance to
almost all β-lactams (MRSE)
• MRSE Edmonton - ~50-70%
Resistance to Penicillin
Streptococcus pyogenes (Group A Streptococci)
• All susceptible!
NO REPORTS OF RESISTANCE
Some reports of reduced suscept
Resistance to Penicillin
Viridans Group of Streptococci
• resistance due to β-lactamase and transfer of
resistance gene PBP2b from S. pneumoniae
- (penicillin resistant UAH 20% 2012 ; 44% 2019)
Resistance to Penicillin
Streptococcus agalactiae (Group B Streptococci)
• Canada - All susceptible
• 4 clones with reduced susceptibility to β-lactams
reported due to point mutation
(AAC Aug 2008, pg 2915-2918)
• (resistant strain reported in cattle - altered PBP)
Resistance to Penicillin
Streptococcus pneumoniae
• S. Africa, Spain (50%), U.S.A. (30 - 50%),
Canada (~20%)
- altered PBPs
• Dynalife Community (% non-susceptible)
- 2006 - 11% non-susceptible
- 2019 - 9% non-susceptible
- 2019 - 12% (Meningeal*)
Resistance to Penicillin
Enterococci
• β-lactamase production, altered PBPs rare with E.
faecalis, but more common with E. faecium
• Enterococcus faecalis
- 100% Susceptible to ampicillin/amoxicillin (2019
Edmonton community)
- 99% Susceptible to ampicillin/amoxicillin (2019 UAH)
• Enterococcus faecium
- 36% susceptible to amp/amox (2019 Edmonton
Community)
- 8% susceptible to amp/amox (2019 UAH)
Resistance to Penicillin
N. gonorrhoeae
- β-lactamase production
- decreased affinity of PBPs
- Can no longer use penicillin empirically for gonorrhea
Resistance to Penicillin
Enterobacterales
Enterobacterales are intrinsically resistant to penicillin due to:
- β-lactamase production
- reduced affinity for PBP
- cell wall impermeability
Summary Penicillin Resistance
see slide 20
Penicillinase-Resistant
Semi-synthetic Penicillins
cloxacillin role?
• Bulky side chain provides β-lactamase resistance with
staphylococci (protects site on β-lactam ring from
bindingto β-lactamase breaking open the β-lactam
ring)
• ↑ activity against β-lactamase producing
staphylococci, but not methicillin-resistant
staphylococci (MRSA, MRSE)
• Cloxacillin has a limited spectrum
- Penicillin and ampicillin are more active against
Streptococci
- Cloxacillin usually only used to treat skin infections
with S. aureus and S. pyogenes
- inactive against Enterococci, Listeria, and Gram
negatives
Aminopenicillins
- Amino group added to side chain
- ↑ entry into cell, ↑ affinity for PBP
• ↑ spectrum against “easily killed” Gram-negatives
(H. influenzae, E. coli, Proteus mirabilis)
• But resistance developing due to β-lactamase
production
- N. gonorrheae, H. influenzae, E. coli, P. mirabilis
• Some resistance due to changes in PBPs
- e.g., some H. influenzae (~5%) have changed PBPs
Comparison of
Ampicillin/Amoxicillin Spectrum to Penicillin G
• more active against
- S. pneumoniae (97% Susceptible – Dynalife Dx 2019)
- Enterococcus
- L. monocytogenes
- ↑ Gram-negative effect, but now many resistant
- % Susceptible Dynalife (Community) 2019
- H. influenzae 76%
- E. coli 56%
- Proteus mirabilis 69%
Ampicillin
- Available IV, IM, PO
- PO → 30-60% absorbed, acid labile, (diarrhea)
• Well-distributed → CSF*, pleural, joint, and peritoneal
fluids
• ↑ incidence skin rash
Amoxicillin
• Only available PO (unless combined with
clavulanic acid – IV formulation available)
• Relative to ampicillin
- ↑ resistance to gastric acid (can take with food)
- ↑ absorption (2 - 2.5 x blood levels of ampicillin)
- less diarrhea
Clavulanic Acid
Inhibitor?
- β-lactamase Inhibitor
- irreversibly binds to β-lactamase (suicide inhibitor)
- combined with amoxicillin (Clavulin®, Augmentin®)
• inhibits plasmid-mediated β-lactamases of
Staphylococci, H. influenzae, M. catarrhalis, some
Enterobacterales (Enterobacteriaceae), B. fragilis
Clavulanic Acid
Characteristics
- well absorbed orally
- t 1/2 1 hour (similar to amoxicillin)
- 25 - 40% excreted unchanged in urine
- excretion not inhibited by probenecid
- few side effects on its own - diarrhea / nausea
- To prevent this:
- adult oral dose clavulanic limited to 125 mg/dose
(i. e., BID-TID) - Maximum dose children 10 mg/kg/day
- does not cross into the CSF well
- adult oral dose clavulanic limited to 125 mg/dose
- To prevent this: